Showing posts with label Humira. Show all posts
Showing posts with label Humira. Show all posts

Thursday, April 11, 2019

Nobel laureate takes stance against allowing research to be intellectual property; The Auburn Plainsman, April 11, 2019

Trice Brown, The Auburn Plainsman; Nobel laureate takes stance against allowing research to be intellectual property

"George Smith, recipient of a 2018 Nobel Prize for Chemistry, spoke to a crowd of students and faculty about the problems that arise from making publicly funded research intellectual property.

Smith said one of the greatest problems facing the scientific research community is the ability of universities to claim intellectual property rights on publicly funded research.

“I think that all research ought not to have intellectual — not to be intellectual property,” Smith said. “It’s the property of everyone.”"

Monday, May 22, 2017

The World’s Best-Selling Drug Just Lost a Key Patent Battle; Fortune, May 18, 2017

Sy Mukherjee, Fortune; 

The World’s Best-Selling Drug Just Lost a Key Patent Battle


"The rheumatoid arthritis and psoriasis medicine has recently been a target of biopharma companies that are trying to make generic Humira copycats called "biosimilars."...

Once the drug does fall off the patent cliff, however, AbbVie could be in for some rough times. Humira sales make up more than 60% of its revenues."